4.2.4 Targeted therapies and immunotherapy

4.2.4 Targeted therapies and immunotherapy

There are several targeted therapies that may be used as part of treatment for colorectal cancer. These include bevacizumab and cetuximab, among others. They are only used for metastatic disease in conjunction with chemotherapy.

There is a role for immunotherapy in selected metastatic cancer cases and currently only in microsatellite unstable tumours.